Drugs that contain Ziconotide Acetate
1. Prialt patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5795864 | TERSERA | Stable omega conopetide formulations |
Jun, 2015
(8 years ago) | |
| US5364842 | TERSERA | Method of producing analgesia |
Dec, 2016
(7 years ago) | |
| US9707270 | TERSERA | Method for administering ω-conopeptide |
Oct, 2024
(5 months from now) | |
| US8653033 | TERSERA | Method for administering omega-conopeptide |
Oct, 2024
(5 months from now) | |
| US8765680 | TERSERA | Method for administering omega-conopeptide |
Oct, 2024
(5 months from now) | |
Market Authorisation Date: 28 December, 2004
Treatment: Analgesia; Treatment of severe chronic pain via intrathecal infusion of ziconotide in patients also receiving morphine; Treatment of pain
Dosage: INJECTABLE;INTRATHECAL
More Information on Dosage
PRIALT family patents
